article thumbnail

Galderma sets price range for supersized $2.6bn IPO in Europe

Pharmaceutical Technology

The dermatology-centric pharma company is likely set for one of the biggest public listings in Europe since 2022.

article thumbnail

Novartis probed by Swiss authorities over ‘unlawful’ patent use

pharmaphorum

The competition authorities in Switzerland said this morning they have carried out a raid on a pharma company – now confirmed to be Novartis – as part of an investigation into a “possible unlawful use of a patent to reduce competitive pressure.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Almirall kicks off another hunt for skin disease therapy partnerships

pharmaphorum

Spanish drugmaker Almirall has launched another search for early-stage research projects that it can partner in dermatology, its core area of expertise. ” Earlier iterations have focused on immuno-inflammatory skin conditions, novel targets for skin health and pharmacological validated research models in skin diseases.

article thumbnail

Almirall and IRB Barcelona team up to tackle skin disease

pharmaphorum

Two Spanish pharma companies are joining forces to identify new oral treatments for immune-inflammatory skin diseases with high unmet medical needs. It’s an amazing opportunity to put their knowledge and experience in dermatology, together with our expertise in molecular glues to accelerate drug discovery to treat skin diseases.

article thumbnail

Johnson & Johnson Pulls Neutrogena and Aveeno Spray Sunscreens Over Benzene Contamination

XTalks

Related: Google Launches AI-Based Dermatology Assist Tool. In light of the benzene contamination, “While the use of these products would not be expected to cause adverse health consequences,” the company says it was the “right decision” to ask customers to stop using them. Benzene is a colorless flammable liquid that has a sweet odor.

article thumbnail

Almirall, Happify partner on digital tool for psoriasis mental health

pharmaphorum

Popit’s technology has been clinically validated to reduce the number of missed doses and is already being used by several pharma companies. Happify meanwhile has been partnering with healthcare organisations to develop other versions of its digital health platform targeted at specific health conditions.

article thumbnail

Takeaways From The American Academy of Dermatology’s Annual Conference

Pharma Marketing Network

The American Academy of Dermatology (AAD) held its annual conference last weekend, and it was my privilege to be in attendance. As COVID-19 had put the brakes on the show for the past two years, that same sentiment was shared by most of the attendees and exhibitors this year.